Cargando…
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Recurrences of COVID-19 were observed in a patient with long-term usage of hydroxychloroquine, leflunomide, and glucocorticoids due to her 30-year history of rheumatoid arthritis (RA). Tocilizumab was applied and intended to target both COVID-19 and RA. However, disease of this patient aggravated af...
Autores principales: | Cai, Shaozhe, Sun, Wei, Li, Ming, Dong, Lingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303585/ https://www.ncbi.nlm.nih.gov/pubmed/32562070 http://dx.doi.org/10.1007/s10067-020-05234-w |
Ejemplares similares
-
Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis
por: Giraud, C., et al.
Publicado: (2016) -
Psoas abscess during treatment with intravenous tocilizumab in a patient with rheumatoid arthritis: a case-based review
por: Vajdić, Ines Doko, et al.
Publicado: (2021) -
COVID-19 in rheumatoid arthritis cases: an Iranian referral center experience
por: Shadmanfar, Soraya, et al.
Publicado: (2020) -
Accelerated subcutaneous nodulosis in patients with rheumatoid arthritis treated with tocilizumab: a case series
por: Talotta, Rossella, et al.
Publicado: (2018) -
Rheumatoid arthritis with pachymeningitis – a case presentation and review of the literature
por: Joshi, Sanyukta, et al.
Publicado: (2020)